Latest Methadone Stories
Enteric-Coated Buprenorphine Product Candidates (BuTab, REL-1028) to be Compared with Marketed Intravenous and Sublingual Formulations NEW YORK, March 24, 2015 /PRNewswire/ -- Relmada
A case study by Healthcare Data Solutions (HDS), confirms that its Prescriber Validation Subscription Service (PVSS) solution helped pharmacies save millions in potential hydrocodone fines
A new form of Naltrexone, Vivitrol, has been proven effective in treating nearly every patient prescribed the opiate blocking medication by the Washington County Health Department, according to
Harbor Village comments on New Hampshire’s approval of Bill 270, which provides protection from arrest and prosecution to victims of overdose, according to an article by Union Leader.
Results demonstrate limits of immunoassay compared to laboratory-based testing in addiction treatment and risk management SAN DIEGO, March 19, 2015 /PRNewswire/ -- The Millennium Research
PARSIPPANY, N.J., March 19, 2015 /PRNewswire/ -- Daiichi Sankyo, Inc.
Harbor Village Detox comments on the effectiveness of naltrexone, which is a non opiate based drug helping drug addicts to overcome heroin addiction and opiate abuse.
TRENTON, N.J., March 17, 2015 /PRNewswire-USNewswire/ -- The majority of New Jersey residents want the legislature to mandate that their doctor tell them if their prescription medicine is addictive
Novel product candidate being developed for the treatment of neuropathic pain demonstrates good safety profile even at higher doses NEW YORK, March 17, 2015 /PRNewswire/ -- Relmada
--Shionogi's S-718632 investigational new drug application was submitted and is open-- WAYNE, Pa., March 17, 2015 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully
- The governor of a province or people.